News 10.07.22

GIBS 2022 Annual Conference

Mirpharm will support an international conference dedicated to interstitial cystitis

Moscow, July 2022


International conference of urologists GIBS (GLOBAL INTERSTITIAL CYSTITIS, BLADDER PAINSOCIETY) dedicated to the diagnosis and treatment of interstitial cystitis will be held on August 27 and 28 in Mumbai. Leading urologists from 7 countries will speak at the conference.


Mir-Pharm companies will act as a partner of the event, providing the Russian urological community with access to the conference materials. Support for the event is designed to increase the awareness of Russian urologists about the methods of diagnosis and treatment of IC.

The problem of treatment of interstitial cystitis is one of the most difficult tasks in modern urology. Therefore, she was honored with the creation of a separate society dedicated to the fight against interstitial cystitis.


In July 2022, Mir-Pharm successfully registered in Russia a drug for the treatment of interstitial cystitis - Miropentane, which is the only FDA-approved oral drug and is included in the first line of therapy for painful bladder syndrome in clinical recommendations.


Miropentane (INN - pentosan sodium polysulfate) is used in the treatment of interstitial cystitis and has a long-term anti-inflammatory effect and relieves pain, proven in national and international clinical studies.

Miropentan is the only officially registered drug for the treatment of interstitial cystitis in Russia.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.